News

Apr. 22, 2025 — When receiving a lung transplant, one of the most important complications to look out for is chronic lung allograft dysfunction, known as CLAD. Preventing this complication for ...
A Bay Area woman given just two years to live after being diagnosed with lung cancer has lived for eight. Statistics show she is part of a group of young never-smoking Asian American women who are ...
A woman from Anglesey who was diagnosed with stage 3 lung cancer 18 months after first noticing something was wrong is urging others to get symptoms checked without delay. It comes as new ...
“The AI-enabled CXRs revealed important findings, including lung nodules at high risk for cancer in nearly 50,000 people – prompting their referral for further testing and possible diagnosis ...
The Trump administration plans to terminate federal workers focused on preventing and responding to work-related illnesses, including "black lung" disease in coal miners, according to an internal ...
Researchers discovered a distinct plasma biomarker signature involving proteins like CCL3 and IL-18, associated with cell death, lung injury, and platelet activation. These findings offer ...
Arsenal manager Mikel Arteta says midfielder Jorginho is "recovering well" from a lung injury and might play again this season. The 33-year-old's last appearance came on 12 April when he was ...
Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...
These chemicals have been linked to lung inflammation, organ damage, respiratory illnesses and even some types of cancer. University of Vienna scientists found the level of fumes in the air was ...
New research has confirmed there is an unmistakeable link between vaping and irreversible lung disease. The study published by Johns Hopkins University tracked 250,000 people - and discovered that ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).
Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...